Actively Recruiting

All Genders
NCT07466784

CEDRN: Opioid Registry

Led by University of British Columbia · Updated on 2026-03-12

7200

Participants Needed

1

Research Sites

283 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Unregulated opioids remain a leading driver of preventable mortality and potential years of life lost in Canada. Emergency departments (EDs)-open 24/7 and frequently accessed by people who use drugs-offer critical opportunities to reverse toxicity, mitigate harm, and initiate treatment. Yet, high quality evidence to guide ED care for patients with opioid poisoning and concomitant opioid dependence or opioid use disorder is limited. The investigators aim to establish a pan Canadian registry of patients presenting to EDs with opioid poisoning to generate timely, practice informing evidence. The investigators will create the Canadian Emergency Department Research Network (CEDRN) Opioid Registry across participating EDs nationwide. Using automated screening of electronic health records (EHRs), the investigators will identify consecutive patients of all ages with suspected or confirmed opioid poisoning at their index ED visit. The project's objectives are to establish a pan-Canadian registry of Emergency Department patients presenting with opioid poisoning, harmonize data collection across participating sites, describe variations in patient characteristics, clinical practice and outcomes, and derive a clinical decision rule to predict the risk of dying within 60 days. The expected outcomes include advancing healthcare delivery, improving patient and provider experiences, and enhancing population health and health system sustainability for individuals with opioid poisoning. This research is crucial for addressing the opioid crisis in Canada and has the potential to significantly impact patient care and outcomes.

CONDITIONS

Official Title

CEDRN: Opioid Registry

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who arrive at the emergency department with discharge diagnoses of overdose or intoxication from Percocet, Oxycontin, Oxycodone, Methadone, Heroin, Fentanyl, Codeine, Carfentanil, or opioid withdrawal
  • Patients who have had medications ordered during the present or past two years' hospital visits including Buprenorphine, Buprenorphine-naloxone, Methadone, Kadian/Morphine long-acting, Naloxone, or Naloxone kit
  • Patients with inpatient discharge diagnoses of opioid use disorder (mild, moderate, or severe), opioid-related disorders, adverse effects or poisoning by polysubstance use, opioid intoxication or withdrawal, intoxication or withdrawal from any substance, adverse effects or poisoning by opioids, benzodiazepines, antiepileptic or sedative-hypnotic drugs, or any psychoactive substance abuse resulting in intoxication, withdrawal, or adverse effects
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Vancouver General Hospital

Vancouver, British Columbia, Canada, V5Z 1M9

Actively Recruiting

Loading map...

Research Team

J

Jeffrey P Hau, MSc

CONTACT

V

Vi Ho, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here